instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'BISOPROLOL'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the administration route of drug 'BROMFENAC SODIUM'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Ophthalmic | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the administration route of drug 'CALCIUM GLUCONATE'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the administration route of drug 'CARTEOLOL HYDROCHLORIDE'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Ophthalmic | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the administration route of drug 'CARTEOLOL'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Ophthalmic | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,817,303 | 2021-01-01 |
What was the administration route of drug 'DORZOLAMIDE HYDROCHLORIDE'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Ophthalmic | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the administration route of drug 'DOXAZOSIN MESYLATE'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the administration route of drug 'EDOXABAN TOSYLATE'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the administration route of drug 'REBAMIPIDE'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Ophthalmic | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the administration route of drug 'TRAVOPROST'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Ophthalmic | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the administration route of drug 'VERAPAMIL HYDROCHLORIDE'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the dosage of drug 'CARTEOLOL HYDROCHLORIDE'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | LEFT EYE | DrugDosageText | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the dosage of drug 'EDOXABAN TOSYLATE'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | 30MG/DAY | DrugDosageText | CC BY-NC-ND | 32830185 | 18,817,303 | 2021-01-01 |
What was the dosage of drug 'TRAVOPROST'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | LEFT EYE | DrugDosageText | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the outcome of reaction 'Bradycardia'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Recovered | ReactionOutcome | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the outcome of reaction 'Shock'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Recovered | ReactionOutcome | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the outcome of reaction 'Sinus node dysfunction'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Recovered | ReactionOutcome | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | AMPHOTERICIN B, ASPIRIN, AZITHROMYCIN ANHYDROUS, HYDROXYCHLOROQUINE, MEROPENEM, METFORMIN HYDROCHLORIDE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, RAMIPRIL, SIMVASTATIN, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 32837879 | 19,468,704 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | AMPHOTERICIN B, AZITHROMYCIN ANHYDROUS, HYDROXYCHLOROQUINE, MEROPENEM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 32837879 | 19,458,392 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | AMPHOTERICIN B, ASPIRIN, AZITHROMYCIN ANHYDROUS, HYDROXYCHLOROQUINE, MEROPENEM, METFORMIN HYDROCHLORIDE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, RAMIPRIL, SIMVASTATIN, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 32837879 | 19,468,704 | 2021-03 |
What is the weight of the patient? | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | 90 kg. | Weight | CC BY-NC-ND | 32837879 | 19,458,392 | 2021-03 |
What was the administration route of drug 'AMPHOTERICIN B'? | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 32837879 | 19,468,704 | 2021-03 |
What was the administration route of drug 'AZITHROMYCIN ANHYDROUS'? | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32837879 | 19,468,704 | 2021-03 |
What was the administration route of drug 'HYDROXYCHLOROQUINE'? | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32837879 | 19,468,704 | 2021-03 |
What was the administration route of drug 'MEROPENEM'? | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 32837879 | 19,468,704 | 2021-03 |
What was the administration route of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 32837879 | 19,468,704 | 2021-03 |
What was the dosage of drug 'MEROPENEM'? | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | 1 G, 2X/DAY | DrugDosageText | CC BY-NC-ND | 32837879 | 19,458,392 | 2021-03 |
What was the outcome of reaction 'Drug ineffective'? | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | Fatal | ReactionOutcome | CC BY-NC-ND | 32837879 | 19,458,392 | 2021-03 |
What was the outcome of reaction 'Off label use'? | Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
We report a case of severe COVID-19 pneumonia complicated by fatal co-infection with a multi-triazole resistant Aspergillus fumigatus and highlight the importance of recognising the significance of Aspergillus sp. isolatio... | Fatal | ReactionOutcome | CC BY-NC-ND | 32837879 | 19,458,392 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DEXAMETHASONE, HEPARIN SODIUM, HYDROXYCHLOROQUINE, IMIPENEM, LOPINAVIR\RITONAVIR, OSELTAMIVIR, VANCOMYCIN | DrugsGivenReaction | CC BY | 32837881 | 19,203,398 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic acidosis'. | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DEXAMETHASONE, HEPARIN SODIUM, HYDROXYCHLOROQUINE, IMIPENEM, LOPINAVIR\RITONAVIR, OSELTAMIVIR, VANCOMYCIN | DrugsGivenReaction | CC BY | 32837881 | 19,203,398 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DEXAMETHASONE, HEPARIN SODIUM, HYDROXYCHLOROQUINE, IMIPENEM, LOPINAVIR\RITONAVIR, OSELTAMIVIR, VANCOMYCIN | DrugsGivenReaction | CC BY | 32837881 | 19,203,398 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DEXAMETHASONE, HEPARIN SODIUM, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, OSELTAMIVIR | DrugsGivenReaction | CC BY | 32837881 | 19,079,816 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal tubular necrosis'. | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DEXAMETHASONE, HEPARIN SODIUM, HYDROXYCHLOROQUINE, IMIPENEM, LOPINAVIR\RITONAVIR, OSELTAMIVIR, VANCOMYCIN | DrugsGivenReaction | CC BY | 32837881 | 19,203,398 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'SARS-CoV-2 test positive'. | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DEXAMETHASONE, HEPARIN SODIUM, HYDROXYCHLOROQUINE, IMIPENEM, LOPINAVIR\RITONAVIR, OSELTAMIVIR, VANCOMYCIN | DrugsGivenReaction | CC BY | 32837881 | 19,203,398 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular device infection'. | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DEXAMETHASONE, HEPARIN SODIUM, HYDROXYCHLOROQUINE, IMIPENEM, LOPINAVIR\RITONAVIR, OSELTAMIVIR, VANCOMYCIN | DrugsGivenReaction | CC BY | 32837881 | 19,203,398 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Viral load increased'. | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DEXAMETHASONE, HEPARIN SODIUM, HYDROXYCHLOROQUINE, IMIPENEM, LOPINAVIR\RITONAVIR, OSELTAMIVIR, VANCOMYCIN | DrugsGivenReaction | CC BY | 32837881 | 19,203,398 | 2021-03 |
What was the outcome of reaction 'Acinetobacter infection'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Recovered | ReactionOutcome | CC BY | 32837881 | 19,154,617 | 2021-03 |
What was the outcome of reaction 'Acute respiratory distress syndrome'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Fatal | ReactionOutcome | CC BY | 32837881 | 19,154,617 | 2021-03 |
What was the outcome of reaction 'Aspergillus infection'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Fatal | ReactionOutcome | CC BY | 32837881 | 19,203,398 | 2021-03 |
What was the outcome of reaction 'Bronchopulmonary aspergillosis'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Fatal | ReactionOutcome | CC BY | 32837881 | 19,154,617 | 2021-03 |
What was the outcome of reaction 'Candida infection'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Recovered | ReactionOutcome | CC BY | 32837881 | 19,203,398 | 2021-03 |
What was the outcome of reaction 'Enterococcal infection'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Recovered | ReactionOutcome | CC BY | 32837881 | 19,154,617 | 2021-03 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Fatal | ReactionOutcome | CC BY | 32837881 | 19,203,398 | 2021-03 |
What was the outcome of reaction 'Pneumonia'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Fatal | ReactionOutcome | CC BY | 32837881 | 19,154,617 | 2021-03 |
What was the outcome of reaction 'SARS-CoV-2 test positive'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Fatal | ReactionOutcome | CC BY | 32837881 | 19,203,398 | 2021-03 |
What was the outcome of reaction 'Sepsis'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Fatal | ReactionOutcome | CC BY | 32837881 | 19,203,398 | 2021-03 |
What was the outcome of reaction 'Staphylococcal infection'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Recovered | ReactionOutcome | CC BY | 32837881 | 19,154,617 | 2021-03 |
What was the outcome of reaction 'Vascular device infection'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Recovered | ReactionOutcome | CC BY | 32837881 | 19,203,398 | 2021-03 |
What was the outcome of reaction 'Viral load increased'? | Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has be... | Fatal | ReactionOutcome | CC BY | 32837881 | 19,203,398 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Ischemic Necrosis of Lower Extremity in COVID-19: A Case Report.
Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an acute infectious disease that spreads mainly via the respiratory route. Elderly patients or those with underlying diseases are more... | ASPIRIN, CLOPIDOGREL BISULFATE, ENOXAPARIN SODIUM, EPINEPHRINE | DrugsGivenReaction | CC BY-NC-SA | 32863298 | 18,902,435 | 2021-01-01 |
What was the administration route of drug 'ENOXAPARIN SODIUM'? | Ischemic Necrosis of Lower Extremity in COVID-19: A Case Report.
Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an acute infectious disease that spreads mainly via the respiratory route. Elderly patients or those with underlying diseases are more... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-SA | 32863298 | 18,902,435 | 2021-01-01 |
What was the outcome of reaction 'Drug ineffective'? | Ischemic Necrosis of Lower Extremity in COVID-19: A Case Report.
Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an acute infectious disease that spreads mainly via the respiratory route. Elderly patients or those with underlying diseases are more... | Fatal | ReactionOutcome | CC BY-NC-SA | 32863298 | 18,902,435 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia viral'. | Two Cases of Primary Rhinovirus Pneumonia with Multiple Pulmonary Nodules.
Two patients, a 60-year-old man and 43-year-old woman, presented to our hospital with symptoms of respiratory tract infection. These patients showed imaging findings of multiple small nodules, ground-glass opacities, and consolidations. In case ... | PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 32863361 | 19,777,698 | 2021-02-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhinovirus infection'. | Two Cases of Primary Rhinovirus Pneumonia with Multiple Pulmonary Nodules.
Two patients, a 60-year-old man and 43-year-old woman, presented to our hospital with symptoms of respiratory tract infection. These patients showed imaging findings of multiple small nodules, ground-glass opacities, and consolidations. In case ... | PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 32863361 | 19,777,698 | 2021-02-01 |
What was the outcome of reaction 'Pneumonia viral'? | Two Cases of Primary Rhinovirus Pneumonia with Multiple Pulmonary Nodules.
Two patients, a 60-year-old man and 43-year-old woman, presented to our hospital with symptoms of respiratory tract infection. These patients showed imaging findings of multiple small nodules, ground-glass opacities, and consolidations. In case ... | Recovered | ReactionOutcome | CC BY-NC-ND | 32863361 | 19,777,698 | 2021-02-01 |
What was the outcome of reaction 'Rhinovirus infection'? | Two Cases of Primary Rhinovirus Pneumonia with Multiple Pulmonary Nodules.
Two patients, a 60-year-old man and 43-year-old woman, presented to our hospital with symptoms of respiratory tract infection. These patients showed imaging findings of multiple small nodules, ground-glass opacities, and consolidations. In case ... | Recovered | ReactionOutcome | CC BY-NC-ND | 32863361 | 19,777,698 | 2021-02-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus viraemia'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 32869551 | 19,460,124 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epstein-Barr viraemia'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 32869551 | 19,460,124 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Human herpesvirus 6 infection'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Legionella infection'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 32869551 | 19,460,124 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphopenia'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 32869551 | 19,460,124 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary mass'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 32869551 | 19,460,124 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary necrosis'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 32869551 | 19,460,124 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | ALEMTUZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
What was the dosage of drug 'ALEMTUZUMAB'? | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | 1 MG/KG | DrugDosageText | CC BY-NC | 32869551 | 19,460,124 | 2021-09 |
What was the outcome of reaction 'Lymphopenia'? | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | Fatal | ReactionOutcome | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | Fatal | ReactionOutcome | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
What was the outcome of reaction 'Nausea'? | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | Recovered | ReactionOutcome | CC BY-NC | 32869551 | 19,460,124 | 2021-09 |
What was the outcome of reaction 'Pyrexia'? | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | Fatal | ReactionOutcome | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
What was the outcome of reaction 'Vomiting'? | Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection.
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report fo... | Fatal | ReactionOutcome | CC BY-NC | 32869551 | 19,446,308 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Basedow^s disease'. | Graves' Disease after Adrenalectomy for Cushing's Syndrome.
A 44-year-old woman presented with a 3-month history of back pain, gait disturbance, and insomnia. She had moon face and central obesity but no goiter. Cushing's syndrome due to left adrenal adenoma was diagnosed. She also had low triiodothyronine syndrome and... | HYDROCORTISONE | DrugsGivenReaction | CC BY-NC-ND | 32893226 | 19,236,992 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Goitre'. | Graves' Disease after Adrenalectomy for Cushing's Syndrome.
A 44-year-old woman presented with a 3-month history of back pain, gait disturbance, and insomnia. She had moon face and central obesity but no goiter. Cushing's syndrome due to left adrenal adenoma was diagnosed. She also had low triiodothyronine syndrome and... | HYDROCORTISONE | DrugsGivenReaction | CC BY-NC-ND | 32893226 | 19,236,992 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Graves' Disease after Adrenalectomy for Cushing's Syndrome.
A 44-year-old woman presented with a 3-month history of back pain, gait disturbance, and insomnia. She had moon face and central obesity but no goiter. Cushing's syndrome due to left adrenal adenoma was diagnosed. She also had low triiodothyronine syndrome and... | HYDROCORTISONE | DrugsGivenReaction | CC BY-NC-ND | 32893226 | 19,236,992 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypothalamic pituitary adrenal axis suppression'. | Graves' Disease after Adrenalectomy for Cushing's Syndrome.
A 44-year-old woman presented with a 3-month history of back pain, gait disturbance, and insomnia. She had moon face and central obesity but no goiter. Cushing's syndrome due to left adrenal adenoma was diagnosed. She also had low triiodothyronine syndrome and... | HYDROCORTISONE | DrugsGivenReaction | CC BY-NC-ND | 32893226 | 19,236,992 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Inappropriate thyroid stimulating hormone secretion'. | Graves' Disease after Adrenalectomy for Cushing's Syndrome.
A 44-year-old woman presented with a 3-month history of back pain, gait disturbance, and insomnia. She had moon face and central obesity but no goiter. Cushing's syndrome due to left adrenal adenoma was diagnosed. She also had low triiodothyronine syndrome and... | HYDROCORTISONE | DrugsGivenReaction | CC BY-NC-ND | 32893226 | 19,236,992 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malaise'. | Graves' Disease after Adrenalectomy for Cushing's Syndrome.
A 44-year-old woman presented with a 3-month history of back pain, gait disturbance, and insomnia. She had moon face and central obesity but no goiter. Cushing's syndrome due to left adrenal adenoma was diagnosed. She also had low triiodothyronine syndrome and... | HYDROCORTISONE | DrugsGivenReaction | CC BY-NC-ND | 32893226 | 19,236,992 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Parathyroid gland enlargement'. | Graves' Disease after Adrenalectomy for Cushing's Syndrome.
A 44-year-old woman presented with a 3-month history of back pain, gait disturbance, and insomnia. She had moon face and central obesity but no goiter. Cushing's syndrome due to left adrenal adenoma was diagnosed. She also had low triiodothyronine syndrome and... | HYDROCORTISONE | DrugsGivenReaction | CC BY-NC-ND | 32893226 | 19,236,992 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachycardia'. | Graves' Disease after Adrenalectomy for Cushing's Syndrome.
A 44-year-old woman presented with a 3-month history of back pain, gait disturbance, and insomnia. She had moon face and central obesity but no goiter. Cushing's syndrome due to left adrenal adenoma was diagnosed. She also had low triiodothyronine syndrome and... | HYDROCORTISONE | DrugsGivenReaction | CC BY-NC-ND | 32893226 | 19,236,992 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastric ulcer'. | Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.
OBJECTIVE
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with poor prognosis and limited treatment options. Cisplatin plus pemetrexed is the only approved first-line t... | BEVACIZUMAB, CISPLATIN, PEMETREXED | DrugsGivenReaction | CC BY-NC | 32893992 | 18,306,165 | 2021-06 |
What was the administration route of drug 'BEVACIZUMAB'? | Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.
OBJECTIVE
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with poor prognosis and limited treatment options. Cisplatin plus pemetrexed is the only approved first-line t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 32893992 | 18,306,165 | 2021-06 |
What was the administration route of drug 'CISPLATIN'? | Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.
OBJECTIVE
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with poor prognosis and limited treatment options. Cisplatin plus pemetrexed is the only approved first-line t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 32893992 | 18,306,165 | 2021-06 |
What was the administration route of drug 'PEMETREXED'? | Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.
OBJECTIVE
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with poor prognosis and limited treatment options. Cisplatin plus pemetrexed is the only approved first-line t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 32893992 | 18,306,165 | 2021-06 |
What was the dosage of drug 'BEVACIZUMAB'? | Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.
OBJECTIVE
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with poor prognosis and limited treatment options. Cisplatin plus pemetrexed is the only approved first-line t... | WAS ADMINISTERED OVER 30-90 MIN | DrugDosageText | CC BY-NC | 32893992 | 18,306,165 | 2021-06 |
What was the dosage of drug 'CISPLATIN'? | Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.
OBJECTIVE
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with poor prognosis and limited treatment options. Cisplatin plus pemetrexed is the only approved first-line t... | ADMINISTERED OVER 2 H , CYCLES BEING REPEATED EVERY 3 WEEKS | DrugDosageText | CC BY-NC | 32893992 | 18,306,165 | 2021-06 |
What was the dosage of drug 'PEMETREXED'? | Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.
OBJECTIVE
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with poor prognosis and limited treatment options. Cisplatin plus pemetrexed is the only approved first-line t... | ADMINISTERED OVER 10 MIN., CYCLES BEING REPEATED EVERY 3 WEEKS | DrugDosageText | CC BY-NC | 32893992 | 18,306,165 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depressed level of consciousness'. | Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver cancer affecting adolescents and young adults wit... | CISPLATIN, DEXTROSE, DOXORUBICIN, FLUOROURACIL, INTERFERON ALFA-2A OR INTERFERON ALFA-2B, LACTULOSE, RIFAXIMIN, SODIUM BENZOATE, SODIUM PHENYLBUTYRATE | DrugsGivenReaction | CC BY-NC | 32898940 | 18,380,427 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver cancer affecting adolescents and young adults wit... | CISPLATIN, DEXTROSE, DOXORUBICIN, FLUOROURACIL, INTERFERON ALFA-2A OR INTERFERON ALFA-2B, LACTULOSE, RIFAXIMIN, SODIUM BENZOATE, SODIUM PHENYLBUTYRATE | DrugsGivenReaction | CC BY-NC | 32898940 | 18,380,427 | 2021-01 |
What was the administration route of drug 'SODIUM BENZOATE'? | Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver cancer affecting adolescents and young adults wit... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 32898940 | 18,380,427 | 2021-01 |
What was the dosage of drug 'DEXTROSE'? | Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver cancer affecting adolescents and young adults wit... | 20 GRAM DAILY; | DrugDosageText | CC BY-NC | 32898940 | 18,380,427 | 2021-01 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver cancer affecting adolescents and young adults wit... | DAYS 1 AND 2 (30 MG/M2) | DrugDosageText | CC BY-NC | 32898940 | 18,812,291 | 2021-01 |
What was the dosage of drug 'SODIUM PHENYLBUTYRATE'? | Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver cancer affecting adolescents and young adults wit... | 20 GRAM DAILY; | DrugDosageText | CC BY-NC | 32898940 | 18,380,427 | 2021-01 |
What was the outcome of reaction 'Depressed level of consciousness'? | Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver cancer affecting adolescents and young adults wit... | Recovered | ReactionOutcome | CC BY-NC | 32898940 | 18,380,427 | 2021-01 |
What was the outcome of reaction 'Hyperammonaemic encephalopathy'? | Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver cancer affecting adolescents and young adults wit... | Recovered | ReactionOutcome | CC BY-NC | 32898940 | 18,380,427 | 2021-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.